# Beasley Broadcast Group Inc: financial statements, quarterly

BBGI · Nasdaq · CIK 1099160 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bbgi.md) · [Financials](/companies/bbgi/financials.md) · [Filings](/companies/bbgi/filings.md) · [Insiders](/companies/bbgi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bbgi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [60.1](/filings/0000950170-24-124042.md) | [65.7 d](/filings/0000950170-25-045211.md) | [54.4](/filings/0000950170-25-066442.md) | [60.4](/filings/0000950170-25-107986.md) | [58.2](/filings/0001193125-25-274158.md) | [67.3 d](/filings/0001193125-26-147594.md) | [48.9](/filings/0001193125-26-226602.md) | [53.0](/filings/0001193125-26-352119.md) | [51.0](/filings/0001193125-25-274158.md) | [53.1 d](/filings/0001193125-26-147594.md) | [42.6](/filings/0001193125-26-226602.md) | [44.1](/filings/0001193125-26-352119.md) |
| Operating income | $m | [(85.5)](/filings/0000950170-24-124042.md) | [7.6 d](/filings/0000950170-25-045211.md) | [(1.1)](/filings/0000950170-25-066442.md) | [5.4](/filings/0000950170-25-107986.md) | [1.2](/filings/0001193125-25-274158.md) | [7.6 d](/filings/0001193125-26-147594.md) | [(0.3)](/filings/0001193125-26-226602.md) | [2.9](/filings/0001193125-26-352119.md) | [(0.5)](/filings/0001193125-25-274158.md) | [(230) d](/filings/0001193125-26-147594.md) | [7.7](/filings/0001193125-26-226602.md) | [1.3](/filings/0001193125-26-352119.md) |
| Interest expense | $m | [6.4](/filings/0000950170-24-124042.md) | [6.8 d](/filings/0000950170-25-045211.md) | [5.6](/filings/0000950170-25-066442.md) | [6.1](/filings/0000950170-25-107986.md) | [6.1](/filings/0001193125-25-274158.md) | [3.5 d](/filings/0001193125-26-147594.md) | [3.4](/filings/0001193125-26-226602.md) | [3.3](/filings/0001193125-26-352119.md) | [3.3](/filings/0001193125-25-274158.md) | [3.3 d](/filings/0001193125-26-147594.md) | [3.3](/filings/0001193125-26-226602.md) | [1.5](/filings/0001193125-26-352119.md) |
| Income tax | $m | [(23.3)](/filings/0000950170-24-124042.md) | [2.0 d](/filings/0000950170-25-045211.md) | [(0.4)](/filings/0000950170-25-066442.md) | [(0.1)](/filings/0000950170-25-107986.md) | [(1.3)](/filings/0001193125-25-274158.md) | [0.5 d](/filings/0001193125-26-147594.md) | [(1.6)](/filings/0001193125-26-226602.md) | [0.3](/filings/0001193125-26-352119.md) | [(0.3)](/filings/0001193125-25-274158.md) | [(43.1) d](/filings/0001193125-26-147594.md) | [1.3](/filings/0001193125-26-226602.md) | [7.3](/filings/0001193125-26-352119.md) |
| Net income | $m | [(67.5)](/filings/0000950170-24-124042.md) | [6.4 d](/filings/0000950170-25-045211.md) | [0.0](/filings/0000950170-25-066442.md) | [(0.3)](/filings/0000950170-25-107986.md) | [(3.6)](/filings/0001193125-25-274158.md) | [(2.1) d](/filings/0001193125-26-147594.md) | [(2.7)](/filings/0001193125-26-226602.md) | [(0.2)](/filings/0001193125-26-352119.md) | [(3.6)](/filings/0001193125-25-274158.md) | [(190) d](/filings/0001193125-26-147594.md) | [3.2](/filings/0001193125-26-226602.md) | [84.3](/filings/0001193125-26-352119.md) |
| Diluted EPS | $ per share | [(45.08)](/filings/0000950170-24-124042.md) | not reported | [0.01](/filings/0000950170-25-066442.md) | [(0.18)](/filings/0000950170-25-107986.md) | [(2.33)](/filings/0001193125-25-274158.md) | not reported | [(1.50)](/filings/0001193125-26-226602.md) | [(0.09)](/filings/0001193125-26-352119.md) | [(1.97)](/filings/0001193125-25-274158.md) | not reported | [1.77](/filings/0001193125-26-226602.md) | [45.95](/filings/0001193125-26-352119.md) |
| Basic EPS | $ per share | [(45.08)](/filings/0000950170-24-124042.md) | not reported | [0.01](/filings/0000950170-25-066442.md) | [(0.18)](/filings/0000950170-25-107986.md) | [(2.33)](/filings/0001193125-25-274158.md) | not reported | [(1.50)](/filings/0001193125-26-226602.md) | [(0.09)](/filings/0001193125-26-352119.md) | [(1.97)](/filings/0001193125-25-274158.md) | not reported | [1.78](/filings/0001193125-26-226602.md) | [46.47](/filings/0001193125-26-352119.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [29.7](/filings/0000950170-23-058797.md) | [26.7](/filings/0000950170-25-045211.md) | [27.8](/filings/0000950170-24-057038.md) | [33.3](/filings/0000950170-24-097026.md) | [27.8](/filings/0000950170-24-124042.md) | [13.8](/filings/0001193125-26-147594.md) | [12.2](/filings/0000950170-25-066442.md) | [13.7](/filings/0000950170-25-107986.md) | [14.3](/filings/0001193125-25-274158.md) | [9.9](/filings/0001193125-26-352119.md) | [6.4](/filings/0001193125-26-226602.md) | [6.7](/filings/0001193125-26-352119.md) |
| Current assets | $m | [91.3](/filings/0000950170-23-058797.md) | [86.6](/filings/0000950170-25-045211.md) | [80.6](/filings/0000950170-24-057038.md) | [88.4](/filings/0000950170-24-097026.md) | [87.6](/filings/0000950170-24-124042.md) | [69.3](/filings/0001193125-26-147594.md) | [62.7](/filings/0000950170-25-066442.md) | [72.7](/filings/0000950170-25-107986.md) | [69.4](/filings/0001193125-25-274158.md) | [60.5](/filings/0001193125-26-352119.md) | [50.9](/filings/0001193125-26-226602.md) | [49.4](/filings/0001193125-26-352119.md) |
| Total assets | $m | [594](/filings/0000950170-23-058797.md) | [574](/filings/0000950170-25-045211.md) | [566](/filings/0000950170-24-057038.md) | [573](/filings/0000950170-24-097026.md) | [571](/filings/0000950170-24-124042.md) | [549](/filings/0001193125-26-147594.md) | [539](/filings/0000950170-25-066442.md) | [548](/filings/0000950170-25-107986.md) | [535](/filings/0001193125-25-274158.md) | [299](/filings/0001193125-26-352119.md) | [282](/filings/0001193125-26-226602.md) | [280](/filings/0001193125-26-352119.md) |
| Current liabilities | $m | [48.3](/filings/0000950170-23-058797.md) | [48.3](/filings/0000950170-25-045211.md) | [42.0](/filings/0000950170-24-057038.md) | [49.9](/filings/0000950170-24-097026.md) | [54.7](/filings/0000950170-24-124042.md) | [53.0](/filings/0001193125-26-147594.md) | [54.5](/filings/0000950170-25-066442.md) | [65.4](/filings/0000950170-25-107986.md) | [60.4](/filings/0001193125-25-274158.md) | [60.2](/filings/0001193125-26-352119.md) | [46.3](/filings/0001193125-26-226602.md) | [40.3](/filings/0001193125-26-352119.md) |
| Total liabilities | $m | [452](/filings/0000950170-23-058797.md) | [425](/filings/0000950170-25-045211.md) | [417](/filings/0000950170-24-057038.md) | [424](/filings/0000950170-24-097026.md) | [426](/filings/0000950170-24-124042.md) | [402](/filings/0001193125-26-147594.md) | [395](/filings/0000950170-25-066442.md) | [404](/filings/0000950170-25-107986.md) | [394](/filings/0001193125-25-274158.md) | [349](/filings/0001193125-26-352119.md) | [328](/filings/0001193125-26-226602.md) | [241](/filings/0001193125-26-352119.md) |
| Long-term debt | $m | [284](/filings/0000950170-23-058797.md) | [264](/filings/0000950170-25-045211.md) | [265](/filings/0000950170-24-057038.md) | [265](/filings/0000950170-24-097026.md) | [265](/filings/0000950170-24-124042.md) | [247](/filings/0001193125-26-147594.md) | [241](/filings/0000950170-25-066442.md) | [239](/filings/0000950170-25-107986.md) | [237](/filings/0001193125-25-274158.md) | [235](/filings/0001193125-26-352119.md) | [218](/filings/0001193125-26-226602.md) | [145](/filings/0001193125-26-352119.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-147594.md) | [4.3](/filings/0000950170-25-066442.md) | [2.8](/filings/0000950170-25-107986.md) | [2.8](/filings/0001193125-25-274158.md) | [2.8](/filings/0001193125-26-352119.md) | [0.0](/filings/0001193125-26-226602.md) | [0.0](/filings/0001193125-26-352119.md) |
| Shareholders' equity | $m | [142](/filings/0000950170-24-124042.md) | [149](/filings/0001193125-25-274158.md) | [149](/filings/0000950170-25-107986.md) | [149](/filings/0001193125-25-274158.md) | [146](/filings/0001193125-25-274158.md) | [147](/filings/0001193125-26-352119.md) | [145](/filings/0001193125-26-352119.md) | [145](/filings/0001193125-26-352119.md) | [141](/filings/0001193125-25-274158.md) | [(49.3)](/filings/0001193125-26-352119.md) | [(46.1)](/filings/0001193125-26-352119.md) | [38.8](/filings/0001193125-26-352119.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(5.0) d](/filings/0000950170-24-124042.md) | [0.3 d](/filings/0000950170-25-045211.md) | [(4.0)](/filings/0000950170-25-066442.md) | [6.6 d](/filings/0000950170-25-107986.md) | [(4.8) d](/filings/0001193125-25-274158.md) | [(1.5) d](/filings/0001193125-26-147594.md) | [(3.5)](/filings/0001193125-26-226602.md) | [3.1 d](/filings/0001193125-26-352119.md) | [(4.9) d](/filings/0001193125-25-274158.md) | [(3.2) d](/filings/0001193125-26-147594.md) | [(3.5)](/filings/0001193125-26-226602.md) | [(11.8) d](/filings/0001193125-26-352119.md) |
| Capital expenditure | $m | [1.0 d](/filings/0000950170-24-124042.md) | [1.1 d](/filings/0000950170-25-045211.md) | [0.9](/filings/0000950170-25-066442.md) | [1.0 d](/filings/0000950170-25-107986.md) | [0.6 d](/filings/0001193125-25-274158.md) | [0.4 d](/filings/0001193125-26-147594.md) | [0.8](/filings/0001193125-26-226602.md) | [0.6 d](/filings/0001193125-26-352119.md) | [2.2 d](/filings/0001193125-25-274158.md) | [1.2 d](/filings/0001193125-26-147594.md) | [0.7](/filings/0001193125-26-226602.md) | [0.8 d](/filings/0001193125-26-352119.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-124042.md) | [0.0 d](/filings/0000950170-25-045211.md) | [0.0](/filings/0000950170-25-066442.md) | [0.0 d](/filings/0000950170-25-107986.md) | [0.1 d](/filings/0001193125-25-274158.md) | [0.0 d](/filings/0001193125-26-147594.md) | [0.0](/filings/0001193125-26-226602.md) | [0.0 d](/filings/0001193125-26-352119.md) | [0.0 d](/filings/0001193125-25-274158.md) | [0.0 d](/filings/0001193125-26-147594.md) | [0.0](/filings/0001193125-26-226602.md) | [0.1 d](/filings/0001193125-26-352119.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [29.7](/filings/0000950170-23-058797.md) | [29.8](/filings/0000950170-24-057038.md) | [29.9](/filings/0000950170-24-097026.md) | [1.5](/filings/0000950170-24-124042.md) | [1.5](/filings/0000950170-25-066442.md) | [1.5](/filings/0000950170-25-107986.md) | [1.5](/filings/0001193125-25-274158.md) | [1.8](/filings/0001193125-26-226602.md) | [1.8](/filings/0001193125-26-352119.md) | [1.8](/filings/0001193125-25-274158.md) | [1.8](/filings/0001193125-26-226602.md) | [1.8](/filings/0001193125-26-352119.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.